
    
      Acthar Gel (repository corticotropin injection) contains a non-bovine analogue of
      adrenocorticotropic hormone (ACTH) for intramuscular or subcutaneous use.

      It was initially approved by the FDA in 1952 and is used for multiple indications.

      This registry will evaluate the use of Acthar Gel for the treatment of MS exacerbations in
      the United States.
    
  